ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

EHP Epistem

85.00
0.00 (0.00%)
Last Updated: 00:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Epistem LSE:EHP London Ordinary Share GB00B1VKB244 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 85.00 - 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Epistem Share Discussion Threads

Showing 101 to 123 of 250 messages
Chat Pages: 10  9  8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
11/5/2014
07:16
Some interesting shareholders
the ghost who walks
27/4/2014
18:29
This share has been a bit like the days of new GOLD mines , the Goldrush and shares in same

Exciting to start with

But it was the sellers of the picks, shovels and mining equipment and services to same that made the money and stayed the course as 99% of the mines went bust

Fact 9 out of 10 small cap pharmas NEVER make it to profitability

Costs of clinical studies run into $ many millions

Roughly 1 in 1,000 new drug compounds makes it from pre-clinical stage to production

Forbes research has just put the cost for a BIG Pharma developing a new drug at $ 5 BILLION

Even they are now joining with each other cos they can't afford that kind of dough

buywell2
27/4/2014
14:40
In the results they said the following, wonder if we get an update:-- In April, we expect to enter the Indian regulatory approval process to complete our TB clinical studies, alongside commencing supplementary Nigerian TB studies in readiness for launch of our TB assay later in the year.-- Also in April, Genedrive(R) is expected to enter preliminary TB clinical studies in the US as a forerunner to a WHO recommendation in 2015.
the ghost who walks
22/4/2014
08:26
Seems good news
the ghost who walks
09/4/2014
14:58
Good announcement s
the ghost who walks
31/3/2014
14:00
I sold out completey about 3 or 4 months ago but bought in again recently. I am dissapointed that the portfolio seems to keep shrinking unexpectedly.
azzi
29/3/2014
15:41
Azzi why don't you sell then?
the ghost who walks
26/3/2014
05:57
Of course gene drive potential is the reason to invest in this share. That's obvious.
the ghost who walks
25/3/2014
11:12
Well I think all Epistems eggs are in one basket now, this is a much higher risk play than the co. I invested in 5 years ago. Genedrive quite simply HAS to deliver in a massive way! Will be watching very, very closely - no further delay will be acceptable to investors.
azzi
25/3/2014
07:47
Agreed--------nevertheless a 'breakthrough' is required to appease shareholders and invite others to take an interest-------so that we all might gain !
asph
25/3/2014
07:18
Nice statement I think
the ghost who walks
22/2/2014
13:08
Thanks Ghost. It would be nice to have a progress update however.
azzi
22/2/2014
11:18
Results said 2nd half 2014 launch
the ghost who walks
16/2/2014
21:04
Am I correct in my understanding that Genedrive will be launched with a 'Tb assay' during Q2 this year. We desperately need this. And I use the term "we" as I re-invested a smallish amount last week, this was based solely on the Genedrive launch.Let's hope this progresses as the CEO proclaimed. Any delay would not be tolerated by the market...or me!
azzi
30/1/2014
18:14
Needs breakthrough ---- they have potential to produce something explosive in medicine
asph
30/1/2014
17:33
Looks good mgt hires
the ghost who walks
29/12/2013
19:41
Hmmm..
I remain perplexed. The recent announcement re- US military evaluation and FIND initiative should have given an upward push for the share price It seems the Genedrive system is now the key focus of attention for EPH, what has happened to all the other ground backing technologies?
The launch of the first genedrive test had better not be delayed - I still feel we are not aware of the full picture here, is the genedrive system really that good? BD walked away from it , right or wrong?
I am a confused long term ex-investor, however I would consider re-investing if I believe the story.

azzi
22/12/2013
11:20
Seems promising agm statement
the ghost who walks
07/12/2013
15:53
Director buy
the ghost who walks
24/11/2013
20:59
Still watching, but without any sort of official update from the company I am still scratching my head as to what has /is going so wrong. All I can assume is that the facts may not match the hype. Well this is AIM!
azzi
19/11/2013
08:16
Can but agree Azzi----------very disappointed with EHP
asph
10/11/2013
20:12
Hmmm....I sense something has significantly changed within Epistem - I can't put my finger on it but after 30 years of investing I am not comfortable to re-invest having completely selling out recently. I sense the company are not being quite as transparent as I had believed...
We now seem to be focusing on Genedrive - yet BD appears to have walked away from this recently - hence the demise of the share price I didn't realise that this project was of such high priority.
Epistem need to re-assure me that they are in control and can launch gendrive on time - because I can't escape the nagging question - WHY did BD walk? I can't quite work this out unless BD knew of something not in the public domain yet.
Watching closely.

azzi
28/10/2013
15:43
Agreed looks very nasty - Big gap down to some 180 - 200p.

Did anyone still holding invest through Beer & Co before it floated ?

pugugly
Chat Pages: 10  9  8  7  6  5  4  3  2  1

Your Recent History

Delayed Upgrade Clock